Article Text

Download PDFPDF

P775 Hepatitis C is not a problem for female transgenders in goiânia, central brazil – preliminary data
  1. Sheila Teles1,
  2. Karlla Caetano2,
  3. Lucila Ferri3,
  4. Megmar Carneiro1,
  5. Márcia Souza2,
  6. Ana Luiza Junqueira2,
  7. Paulie Marcelly Dos Santos Carvalho2,
  8. Brunna De Oliveira4,
  9. Mayara Maria De Almeida2,
  10. Priscilla Junqueira2,
  11. Grazielle Da Costa E Silva2
  1. 1Universidade Federal de Goias, Goiânia, Brazil
  2. 2Universidade Federal de Goias, Faculty of Nursing, Goiânia, Brazil
  3. 3Universidade Federal de Goiás, Regional Jatai, Jatai, Brazil
  4. 4Universidade Federal de Goiás, Institute of Pathology and Public Health, Goiânia, Brazil


Background It is estimated there are 71 million HCV carriers worldwide, and about 1,032,000 live in Brazil. This infection causes acute and chronic hepatitis and is the top cause of liver cancer. The principal mode of HCV dissemination is parenteral via, though some sexual behaviors may facilitate viral transmission such as anal intercourse and unsafe sex. Many transgender women practice behaviors that may put them at risk for HCV infection. The aim of this study is to evaluate the prevalence of HCV infection among transgender women in Goiania, Central Brazil.

Methods From May to December 2018, a total of 180 transgender women were interviewed and tested for anti-HCV using a rapid test (ALERE HCV, Standard Diagnostics, Republic of Korea).

Results None were anti-HCV positive. Of the total, 34.3% reported no or irregular condom use during anal sex with a steady partner, and 34.3% continue this behavior with occasional sexual partners. Other factors: 82.6% had tattoos or piercings; 67.8% used non-injection illicit drugs; 47.8% put industrial silicone into their body; 48.9% reported previous STI, and 48.3% reported bleeding during sexual intercourse. Whereas only 6.7% reported blood transfusion, and 4.2% had a history of illicit injection drug use.

Conclusion These findings suggest hepatitis C is not a problem for transgender women in Goiânia. The low frequency of blood transfusion and illicit injection drug use play a role in HCV prevalence despite of several opportunities for viral transmission.

Disclosure No significant relationships.

  • transgender persons
  • viral STIs
  • seroepidemiology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.